Brett Johnson, MD
Urology · Dallas, TXNPI 1679830442
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Coloplast at 33.5% of the total. Reporting peaked in 2024 at $2,591 and has fallen 57.2% since, to $1,108 in 2025.
Across 73 payments — averaging $120.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$3K
- Boston Scientific$2K
- Calyxo, Inc.$1K
- KARL Storz Endoscopy-america$818
- Cook Medical LLC$475
- Medical Device Business Services, Inc.$432
- plus $741 from 13 others
Across 12 payments — averaging $13,889 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Calyxo, Inc.$148K
- Urogen Pharma, Inc.$18K
What the payments were for
- Consulting fees$96011%
- Travel & lodging$4,01246%
- Food & beverage$3,34238%
- Education$4695%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 7 | $2,940 |
| Boston Scientific | 17 | $1,940 |
| Calyxo, Inc. | 12 | $1,437 |
| KARL Storz Endoscopy-america | 5 | $818 |
| Cook Medical LLC | 8 | $475 |
| Medical Device Business Services, Inc. | 4 | $432 |
| Urogen Pharma, Inc. | 1 | $177 |
| Laborie Medical Technologies Corp. | 2 | $89 |
| Ambu Inc. | 3 | $84 |
| Travere Therapeutics, Inc. | 2 | $82 |
| Johnson & Johnson(2 entities) | 2 | $74 |
| Olympus America Inc. | 2 | $58 |
| Innovation Technologies Inc | 2 | $49 |
| AstraZeneca | 1 | $35 |
| Stryker | 1 | $28 |
| Acera Surgical, Inc. | 1 | $24 |
| Shionogi Inc | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$1,680
- CVAC Aspiration System$1,140
- RETRACE$960
- NEPHROSCOPE MIP M$625
- Lumenis Pulse 120H$335
- JELMYTO$177
- LITHO 150$151
- CVAC$140
- Porges Coloplast$125
- LithoVue$106
- Cook$101
How this compares
$8,783 in reported general payments places this provider in the 75th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 95 | $9,320 |
| MyrbetriqMirabegron | 12 | $7,144 |
| Trospium Chloride | 21 | $2,086 |
| Indapamide | 71 | $1,122 |
| Tamsulosin Hcl | 97 | $1,114 |
| Finasteride | 21 | $811 |
| Oxybutynin Chloride | 11 | $298 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $277 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $181 |
| Ciprofloxacin Hcl | 26 | $113 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $91 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $81 |
| Cephalexin | 17 | $44 |
| Tramadol Hcl | 11 | $23 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other urology in Dallas
- Allen MoreyDallas$914K
- Vitaly MargulisDallas$555K
- Yair LotanDallas$371K
- Claus RoehrbornDallas$169K
- Samantha NealonDallas$89K
- Maia VandykeDallas$79K
- Gary LemackDallas$62K
- Brian LangfordDallas$57K
- Jonathan SeamanDallas$55K
- Andrew von EschenbachMontgomery$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.